Literature DB >> 2278058

In vitro activity of artemisinin, its derivatives, and pyronaridine against different strains of Plasmodium falciparum.

M H Alin1, A Björkman, M Ashton.   

Abstract

The activities of artemisinin (qinghaosu), dihydroartemisinin (dihydroqinghaosu), artemether and pyronaridine were tested in a 48 h in vitro assay against 3 chloroquine-sensitive and one chloroquine-resistant strains of Plasmodium falciparum. Growth inhibition was modelled with a sigmoid Emax model. All compounds markedly inhibited the growth of all strains although, for the chloroquine-resistant strain, merozoites were detected at concentrations as high as 10(-4) M of artemisinin, dihydroartemisinin and artemether. Dihydroartemisinin, artemether and pyronaridine appeared to be more potent than artemisinin, with EC50 values of 4.7-23 nM, 0.98-6.1 nM and 4.4-18 nM respectively, while the EC50 value of artemisinin was 3-108 nM against all 4 strains.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2278058     DOI: 10.1016/0035-9203(90)90129-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  14 in total

Review 1.  Safety assessment of peroxide antimalarials: clinical and chemical perspectives.

Authors:  B K Park; P M O'Neill; J L Maggs; M Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

Review 2.  Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.

Authors:  N J White
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

3.  Effect of food intake on pharmacokinetics of oral artemisinin in healthy Vietnamese subjects.

Authors:  T K Dien; P J de Vries; N X Khanh; R Koopmans; L N Binh; D D Duc; P A Kager; C J van Boxtel
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

4.  New quinoline di-Mannich base compounds with greater antimalarial activity than chloroquine, amodiaquine, or pyronaridine.

Authors:  B M Kotecka; G B Barlin; M D Edstein; K H Rieckmann
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

5.  Caged Garcinia Xanthones, a Novel Chemical Scaffold with Potent Antimalarial Activity.

Authors:  Hangjun Ke; Joanne M Morrisey; Shiwei Qu; Oraphin Chantarasriwong; Michael W Mather; Emmanuel A Theodorakis; Akhil B Vaidya
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

6.  Pharmacokinetics of artemether after oral administration to healthy Thai males and patients with acute, uncomplicated falciparum malaria.

Authors:  K Na Bangchang; J Karbwang; C G Thomas; A Thanavibul; K Sukontason; S A Ward; G Edwards
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

7.  Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania.

Authors:  Sofia Friberg Hietala; Andreas Mårtensson; Billy Ngasala; Sabina Dahlström; Niklas Lindegårdh; Anna Annerberg; Zul Premji; Anna Färnert; Pedro Gil; Anders Björkman; Michael Ashton
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

8.  Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects.

Authors:  Beesan Tan; Himanshu Naik; In-Jin Jang; Kyung-Sang Yu; Lee E Kirsch; Chang-Sik Shin; J Carl Craft; Lawrence Fleckenstein
Journal:  Malar J       Date:  2009-12-18       Impact factor: 2.979

9.  Population pharmacokinetics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malaria.

Authors:  Sadik Mithwani; Leon Aarons; Gilbert O Kokwaro; Oneeb Majid; Simon Muchohi; Geoffrey Edwards; Sumia Mohamed; Kevin Marsh; William Watkins
Journal:  Br J Clin Pharmacol       Date:  2004-02       Impact factor: 4.335

Review 10.  Progress in the research of artemisinin-related antimalarials: an update.

Authors:  H J Woerdenbag; N Pras; W van Uden; T E Wallaart; A C Beekman; C B Lugt
Journal:  Pharm World Sci       Date:  1994-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.